Smart Hydrogel Uses Light and Hydrogen Gas to Heal Infected Wounds
- Authors
- Ze Zhang, Zhipeng Huang, Chenghan Zhang, Weiping Qin, Chenlong Zhong, Shengyan Yin, Qingmin Chen, Xinyue Deng
- Journal
- Colloids and Surfaces. B, Biointerfaces
- Year
- 2026
- DOI
- 10.1016/j.colsurfb.2026.115996
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Polymicrobial Wound Infection
- Body System
- Integumentary
TL;DR
A light-responsive hydrogel combined hydrogen generation, photothermal therapy, and silver-ion release to control polymicrobial infection and promote tissue repair in skin and liver injury models.
Key Finding
A dual-light-activated hydrogel combining heat-based bacteria killing, hydrogen gas therapy, and silver nanoparticles accelerated wound closure and reduced inflammation in animal models of infected liver and skin wounds.
Summary
This study tested a specially designed hydrogel (a gel-like material applied to wounds) that responds to two different wavelengths of light to treat infected wounds in the liver and skin. When exposed to near-infrared light, the hydrogel generates heat to kill bacteria. When exposed to near-ultraviolet light, it produces hydrogen gas, which helps reduce harmful inflammation. Lab and animal experiments showed the hydrogel sped up wound healing, reduced inflammation, and improved tissue repair.
Practical Takeaway
This is early-stage laboratory and animal research — not a human study — so no conclusions can be drawn about benefits for people. It does suggest that hydrogen gas, when delivered locally to a wound site, may help reduce harmful inflammation and support tissue repair, but this application is highly specialized and far from consumer use.
Abstract
An innovative dual-wavelength-responsive GMMC-Pdots-Ag hydrogel was fabricated for the treatment of polymicrobial-infected liver and skin defects. The hydrogel is based on a dynamic double-network architecture composed of gelatin methacryloyl (GelMA), O-carboxymethyl chitosan (O-CMC), and 4-arm poly(ethylene glycol) benzaldehyde (4-arm-PEG-DF), co-loaded with PtOEP-doped T2-DPPT@NH2 polymer dots (Pdots) and L-histidine-stabilized silver nanoparticles (His-Ag NPs). Upon exposure to near-infrared (NIR) radiation at 808 nm, the Pdots induce a localized photothermal effect (PTT). Combined with the weakly alkaline microenvironment and temperature increase, this effect triggers the controlled release of Ag⁺. This dual response enables rapid antibacterial activity and biofilm eradication during the acute stage of inflammation. During the subsequent repair phase, 380 nm near-ultraviolet (NUV) light activates the Pdots to catalytically produce hydrogen (H2). The generated H2 selectively scavenges cytotoxic reactive oxygen species (ROS), especially ·OH and •O2-, and inhibits M1 macrophage polarization through modulation of the NOD-associated MAPK and AP-1 signaling pathways. As a result, it exerts potent anti-inflammatory and antioxidant effects. H2 generation, together with the oxidation by-products, further promotes the release of Ag⁺, creating a self-propagating therapeutic cycle. In vivo studies using skin and liver infection models demonstrated accelerated wound closure, reduced inflammatory infiltration, enhanced angiogenesis, and improved tissue regeneration. Biocompatibility and biosafety tests further validated the hydrogel's potential for biomedical applications. The concept of "one material with three functions," integrating PTT, H2 therapy, and Ag⁺-mediated antimicrobial activity, enables precise, stage-specific, and microenvironment-responsive intervention. This approach highlights the potential of the hydrogel as a platform for smart wound management and clinical translation.